Sutenthcp.com
Title
SUTENTHCP.com - Official SUTENT® (sunitinib malate) HCP Web site homepage
Description
Excerpted from the website description:
- SUTENT® is indicated for the treatment of advanced RCC (please see additional approval information on site) and GIST after disease progression on or intolerance to imatinib mesylate. Site includes information on: SUTENT efficacy and safety data, as well as reimbursement information and professional resources.
Languages
English
Additional Information
Related Domains
External Links
Categories:
- Advanced
- Advanced RCC
- Advanced RCC Treatment
- Advanced Renal Cell Carcinoma
- Carcinoma
- Cell
- GIST
- GIST Disease Progression
- Gastrointestinal Stromal Tumor
- Imatinib Intolerance
- Imatinib Resistance
- Multi-kinase Inhibitor
- Oral Multi-kinase Inhibitor
- RCC
- RCC Treatment
- Renal
- Renal Cell Carcinoma
- SUTENT
- SUTENT Approved
- SUTNET
- Sunitinib Malate
- Treatment